$KITE Kite Pharma, Inc. Insider Trading Week 33/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. in week 33/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Option Exercise | M | 6.89 | 9,000 | 62,010 | 139,000 | |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 61.83 | 671 | 41,488 | 5,218 | 5.9 K to 5.2 K (-11.39 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 61.16 | 4,918 | 300,785 | 5,889 | 10.8 K to 5.9 K (-45.51 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 60.26 | 3,411 | 205,547 | 10,807 | 14.2 K to 10.8 K (-23.99 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Buy | M | 6.89 | 9,000 | 62,010 | 14,218 | 5.2 K to 14.2 K (+172.48 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 161,732 | |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 61.73 | 1,465 | 90,434 | 1,695 | 3.2 K to 1.7 K (-46.36 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 60.99 | 5,322 | 324,589 | 3,160 | 8.5 K to 3.2 K (-62.74 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 60.21 | 2,780 | 167,384 | 8,482 | 11.3 K to 8.5 K (-24.68 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 11,262 | 1.7 K to 11.3 K (+564.42 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 35,813 | |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 118,625 | |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 61.65 | 1,150 | 70,898 | 999 | 2.1 K to 999 (-53.51 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 60.99 | 3,439 | 209,745 | 2,149 | 5.6 K to 2.1 K (-61.54 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 60.15 | 1,556 | 93,593 | 5,588 | 7.1 K to 5.6 K (-21.78 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 7,144 | 6.5 K to 7.1 K (+9.92 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 6,499 | 999 to 6.5 K (+550.55 %) |